Please login to the form below
Soliqua
This page shows the latest Soliqua news and features for those working in and with pharma, biotech and healthcare.
Sanofi wins EU approval for new diabetes combination Suliqua
The long-acting basal insulin and GLP-1 agonist is already on the market in the US as Soliqua, having been approved by the FDA in November last year on the
Latest news
-
Sanofi launches insulin combo Soliqua in US
Sanofi has launched new diabetes combination therapy Soliqua in the US ahead of a rival product from Novo Nordisk. ... the combined price of its two constituent drugs - which could make it more expensive than Soliqua.
-
FDA clears rival diabetes combos from Sanofi and Novo Nordisk
Xultophy set to launch in first half of 2017 while Soliqua is intended for January roll-out. ... Novo Nordisk's Xultophy and Sanofi's Soliqua are both out of the traps and racing towards the US market, with the FDA clearing the two diabetes combinations
-
Sanofi trumpets new IGlarLixi data after regulatory delay
Reports that the combination drug is more effective at controlling glucose than Lantus alone
More from news
Approximately 3 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2018
Acquisition. $244m. Zealand/. Royalty Pharma. Royalty streams and milestones for Soliqua 100/33/.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
- CDC awards over $23m to Johns Hopkins Center for Health Security project
- Looking to start activity on a currently unpromoted pharmaceutical brand?
- Considering a portfolio review?
No results were found
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
